The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Serum Bilirubin and Risk of Respiratory Disease and Death
Abstract
CONTEXT: Serum total bilirubin levels in healthy patients reflect genetic and environmental factors that could influence the risk of developing respiratory disease. OBJECTIVE: To examine the relationship between bilirubin levels and respiratory disease. DESIGN, SETTING, AND PARTICIPANTS: Cohort study among 504,206 adults from a UK primary care research database (the Health Improvement Network) with serum bilirubin levels recorded but no evidence of hepatobiliary or hemolytic disease. Data were recorded between January 1988 and December 2008. MAIN OUTCOME MEASURES: Incidence of chronic obstructive pulmonary disease (COPD), lung cancer, and all-cause mortality. RESULTS: Median bilirubin levels were 0.64 mg/dL (interquartile range, 0.47-0.88 mg/dL) in men and 0.53 mg/dL (interquartile range, 0.41-0.70 mg/dL) in women. There were 1341 cases of lung cancer, 5863 cases of COPD, and 23,103 deaths, with incidence rates of 2.5, 11.9, and 42.5 per 10,000 person-years, respectively. The incidence of lung cancer per 10,000 person-years in men was 5.0 (95% confidence interval [CI], 4.2-6.0) in the first decile category of bilirubin compared with 3.0 (95% CI, 2.3-3.8) in the fifth decile. The corresponding incidences for COPD in men were 19.5 (95% CI,17.7-21.4) and 14.4 (95% CI, 12.7-16.2). The mortality rates per 10,000 person-years in men were 51.3 (95% CI, 48.5-54.2) in the first decile category compared with 38.1 (95% CI, 35.5-40.8) in the fifth decile. The associations were similar for women. After adjusting for other important health indicators, regression estimates for incidence rate of lung cancer per 0.1-mg/dL increase in bilirubin level were an 8% decrease (95% CI, 5%-11%) for men and an 11% decrease (95% CI, 7%-14%) for women. The regression estimate for COPD in men per 0.1-mg/dL increase in bilirubin level was a 6% decrease (95% CI, 5%-7%) and for mortality in men was a 3% decrease (95% CI, 2%-3%) after accounting for other health indicators. The results for COPD and mortality in women were very similar. CONCLUSION: Among patients with normal-range bilirubin levels in primary care practices, relatively higher levels of bilirubin were associated with a lower risk of respiratory disease and all-cause mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, C. P. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0456 · Cited by 2,562
Maguire, A., Blak, B. T., & Thompson, M. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1688 · Cited by 301
Issues in multiple imputation of missing data for large general practice clinical databases
Marston, L., Carpenter, J. R., Walters, K. R., Morris, R. W., Nazareth, I., & Petersen, I. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1934 · Cited by 132 · cited 1×
“” Arecentstudyfoundthattheproportions ofcurrentsmokersrecordedinTHINdata was similar to that in the Health Survey forEngland,inwhichself-reportedsmokingstatushasbeenbiologicallyvalidated using cotinine.(16) Alcohol consumption was grouped into 3 categories: heavy ( 336 g/wk or Read Codes indicating “heavy” or “very he…”
Method
Cited by
Diagnostic criteria and contributors to Gilbert’s syndrome
Wagner, K.-H., Shiels, R. G., Lang, C. A., Seyed Khoei, N., & Bulmer, A. C. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1428526 · Cited by 138
Marston, L., Carpenter, J. R., Walters, K. R., Morris, R. W., Nazareth, I., White, I. R., & Petersen, I. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004958 · Cited by 105
Metadata
- Authors
- Horsfall, L. J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2011-02-16
- Volume
- 305
- Issue
- 7
- Pages
- 691
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1987637787
- Cited by
- 209
- References
- 3
- FWCI
- 6.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.